Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil
Sponsor: Valneva Austria GmbH
Summary
This is an observational, non-interventional, test-negative case-control (TNCC) study to estimate the vaccine effectiveness of VLA1553 against Chikungunya virus in a real-world setting.
Official title: A Test-Negative Case-control Study to Evaluate the Effectiveness of VLA1553 Against Chikungunya Virus Disease During a Pilot Vaccination Strategy in Brazil
Key Details
Gender
All
Age Range
18 Years - 59 Years
Study Type
OBSERVATIONAL
Enrollment
1200
Start Date
2026-02-02
Completion Date
2027-12-31
Last Updated
2026-02-11
Healthy Volunteers
Yes
Conditions
Interventions
Live-attenuated CHIKV vaccine VLA1553
Non-interventional study: VLA1553 is used in the pilot vaccination strategy which is linked to this observational study.
Locations (4)
Universidade Federal Do Ceará
Fortaleza, Ceará, Brazil
Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras
Belo Horizonte, Minas Gerais, Brazil
Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus
Laranjeiras, Sergipe, Brazil
Fundação Faculdade Regional De Medicina De São José Do Rio Preto
São Pedro, São Paulo, Brazil